Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

stem-cell-163711_640

Stem cell therapy fails to improve symptoms of peripheral artery disease

November 16, 2017 Research and Development Stem cells, peripheral artery disease, pharma, stem cell therapy, trial failure

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …
News
arvinas-0004168-2

Genentech cements relationship with Arvinas with $650m deal

November 16, 2017 Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …
News
dia

Navigating the new Clinical Trial Regulation with DIA

November 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
Feature
albert-bourla_300x170px

Pfizer promotes Albert Bourla to newly-created COO role

November 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In a sizeable shake-up of its business operations, Pfizer has promoted Albert Bourla (pictured) to the role of Chief Operating …
Appointment
smart_watch

NHS backs innovative means of cutting diabetes risk

November 15, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk …
News
autolus_-_martin-pule

Promising new CAR-T therapy able to target T-cell lymphoma

November 15, 2017 Research and Development Autolus, CAR T, CAR-T, biotech, drugs, pharma, pharmaceutical

The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …
News

Psoriasis patients at greater risk of type 2 diabetes, study reveals

November 15, 2017 Research and Development diabetes, pharma, psoriasis, type 2 diabetes

Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …
News
kratom_leaf

FDA signals crackdown on controversial painkiller

November 15, 2017 Medical Communications, Research and Development biotech, drugs, kratom, pharma, pharmaceutical

Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to …
News
astrazeneca_building_white

AstraZeneca’s Fasenra scores US approval in severe asthma

November 15, 2017 Research and Development, Sales and Marketing AstraZeneca, Fasenra, MedImmune, asthma

AstraZeneca and MedImmune, the company’s biologics research and development division, have revealed the decision by the FDA to approve Fasenra …
News

WestRock’s Multi Packaging Solutions partners with Smartglyph for SmarterBarcodes

November 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

Multi Packaging Solutions, (MPS), a business of WestRock Company and a leader in value-added print and packaging solutions for the …
News
Press release
dia

Navigating the new Clinical Trial Regulation with DIA

November 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
News
novartis_side_building

Novartis targets specific patient population with strong Ilaris Phase 3 data

November 14, 2017 Manufacturing and Production, Research and Development Ilaris, Novartis, cardiovascular, heart attack, heart disease, pharma

Novartis has presented new Phase 3 data on its cardiovascular drug Ilaris (canakinumab) which demonstrate particular efficacy in a specific …
News

Hansa Medical mourns death of CEO

November 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hansa Medical, pharma

Swedish biopharma firm Hansa Medical broke tragic and unexpected news in November when it announced the death of its CEO …
Appointment
1707_eu-agencies_relocations_website

EMA Headquarters: There’s no place like home

November 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, brexit, drugs, pharma, pharmaceutical

With the result of the Brexit referendum, the future of the EMA’s London headquarters was cast in doubt. Now, 19 …
Feature
novartis_window

Novartis touts longer-lasting AMD rival to Eylea

November 13, 2017 Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Novartis posted strong results for its wet age-related macular degeneration (AMD) drug, by showing superiority against Eylea in Phase 3 …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026